Arja Harila
Professor vid Institutionen för kvinnors och barns hälsa; Barnonkologisk och neurologisk forskning
- E-post:
- arja.harila@uu.se
- Besöksadress:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postadress:
- Akademiska sjukhuset
751 85 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening (2024)
- Educational and occupational outcomes in Swedish children treated for sarcomas (2024)
- Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases (2024)
- Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma (2023)
- Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia (2023)
Alla publikationer
Artiklar
- Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening (2024)
- Educational and occupational outcomes in Swedish children treated for sarcomas (2024)
- Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases (2024)
- Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma (2023)
- Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia (2023)
- An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis (2023)
- Early disc degeneration in radiotherapy-treated childhood brain tumor survivors (2023)
- DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia (2023)
- Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia (2023)
- Childhood lymphoma treatment impacts educational outcomes (2023)
- Parental experiences of the informed consent process in randomized clinical trials-A Nordic study (2023)
- Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial (2023)
- The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols (2023)
- Reply to Ian J. Cohen (2022)
- Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity? (2022)
- Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor (2022)
- Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia (2022)
- A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins (2022)
- Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer (2022)
- Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia (2022)
- Characteristics of white blood cell count in acute lymphoblastic leukemia (2022)
- The human cathelicidin hCAP-18 in serum of children with haemato-oncological diseases (2022)
- Health-related quality of life in long-term survivors of childhood brain tumors (2022)
- Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia (2022)
- Quality of life in mothers and fathers of children treated for acute lymphoblastic leukaemia in Sweden, Finland and Denmark (2022)
- Reduced dose folinic acid rescue after rapid high-dose methotrexate clearance is not associated with increased toxicity in a pediatric cohort (2022)
- High need for intensive care in paediatric acute myeloid leukaemia (2022)
- COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients (2022)
- Severe toxicity free survival (2021)
- Prevalence of and factors influencing vitamin D deficiency in paediatric patients diagnosed with cancer at northern latitudes (2021)
- Skeletal adverse events in childhood cancer survivors (2021)
- ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden (2021)
- Extracorporeal Membrane Oxygenation Support in Children With Hematologic Malignancies in Sweden (2021)
- Neurocognitive impairment, employment, and social status in radiotherapy-treated adult survivors of childhood brain tumors (2021)
- Pattern and Prevalence of Liver Involvement in Pediatric Acute Lymphoblastic and Myeloid Leukemia at Diagnosis (2021)
- Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia (2021)
- Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia (2021)
- Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia (2021)
- Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors (2021)
- Help-seeking behaviour and attitudes towards internet-administered psychological support among adolescent and young adults previously treated for cancer during childhood (2021)
- Trends in age- and sex-adjusted body mass index and the prevalence of malnutrition in children with cancer over 42 months after diagnosis (2020)
- Seizures during treatment of childhood acute lymphoblastic leukemia (2020)
- Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia (2020)
- The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia (2020)
- Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols (2020)
- Vitamin D status in children with leukemia, its predictors, and association with outcome (2020)
- Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia (2020)
- Radiation-induced accelerated aging of the brain vasculature in young adult survivors of childhood brain tumors (2020)
- Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia (2020)
- Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06 (2019)
- Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia (2019)
- Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden (2019)
- Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008 (2019)
- Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6 (2019)
- Microdeletion of 7p12.1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia (2019)
- Vitamin D Status in Children With Hemato-Oncological Diseases in Northern Finland (2019)
- Sweden and Finland need to improve the support provided for the siblings of children with cancer (2019)
- The radiological and clinical follow-up of osteonecrosis in cancer patients (2019)
- Radiation-Induced Meningiomas After Childhood Brain Tumor (2019)
- The PanCareSurFup consortium (2018)
- Vitamin D Status in Children with Leukemia (2018)
- Late vertebral side effects in long-term survivors of irradiated childhood brain tumor (2018)
- Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor (2018)
- NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia (2018)
- Demographic and Disease-Related Factors Impact Bone Turnover and Vitamin D in Children with Hemato-Oncological Diseases
